SCHEMBL21693073

SCHEMBL21693073

N#Cc1c(-c2ccccc2)cc(-c2cccc3c2sc2ccccc23)cc1-c1cccc2c1sc1ccccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.49
SQOR Q9Y6N5 5/20 0.41
PARP14 Q460N5 1/20 0.40
TNKS O95271 1/20 0.37
TNKS2 Q9H2K2 1/20 0.37
F9 P00740 1/20 0.37
PRKDC P78527 3/20 0.37
ADORA2A P29274 1/20 0.37
ADORA1 P30542 1/20 0.37
MAPK1 P28482 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ATM Q13315 1/20 0.36
LIMK1 P53667 1/20 0.36
PIK3CD O00329 1/20 0.35
BRD4 O60885 1/20 0.35
PIK3CA P42336 1/20 0.35
PIK3CB P42338 1/20 0.35
MTOR P42345 1/20 0.35
PIK3CG P48736 1/20 0.35
KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21693070 0.92 ALOX5 (0.48) ALOX5SQORPARP14TNKSTNKS2
SCHEMBL21691585 0.92 ALOX5 (0.51) ALOX5SQORPARP14TNKSTNKS2
SCHEMBL21691615 0.92 ALOX5 (0.41) ALOX5SQORPARP14TNKSTNKS2
SCHEMBL21691623 0.92 ALOX5 (0.44) ALOX5SQORPARP14TNKSTNKS2
SCHEMBL21691572 0.91 ALOX5 (0.49) ALOX5SQORPARP14TNKSPRKDC
SCHEMBL21691666 0.90 ALOX5 (0.51) ALOX5SQORPARP14TNKSTNKS2
SCHEMBL21691569 0.90 ALOX5 (0.48) ALOX5PARP14PRKDCADORA2AADORA1
SCHEMBL21693127 0.90 ALOX5 (0.51) ALOX5SQORPARP14TNKSTNKS2
SCHEMBL21692489 0.90 ALOX5 (0.47) ALOX5SQORPARP14TNKSTNKS2
SCHEMBL21693124 0.89 ALOX5 (0.44) ALOX5SQORPARP14TNKSTNKS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11053228-B2 Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-07-06 US disclosed
US-20200031812-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND SAMSUNG SDI CO., LTD. (KR) 2020-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11053228-B2 Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound CCNL2, ARL1, CRY1 ALOX5 2220/4885SQOR 3254/4885PARP14 1715/4885
US-20200031812-A1 CONDENSED CYCLIC COMPOUND, COMPOSITION INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND CCNL2, ARL1, CRY1 ALOX5 2220/4885SQOR 3254/4885PARP14 1715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.